Dr. Whiting brings extensive experience in medical oncology spanning patient care, early drug discovery, and late-stage global development activities His| Vividion Therapeutics
VVD-214 is the only clinical-stage covalent inhibitor of Werner helicase (WRN) in development worldwide WRN inhibition may provide therapeutic benefit in| Vividion Therapeutics
Due to the limits of traditional drug discovery, the vast majority of known disease-causing proteins remain undrugged. Our mission is to unlock these| Vividion Therapeutics